News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

February 25, 2026

BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines

link

February 17, 2026

Scribe Therapeutics Achieves Second Success Milestone for In Vivo Program in Collaboration with Eli Lilly and Company

link

February 12, 2026

Philips Debuts InkSpace Imaging’s Snuggle Flexible Pediatric MRI Coil

link

Laguna Bio: Basic research on Listeria bacteria leads to unique cancer therapy

link

January 13, 2026

Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors

link

January 12, 2026

Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD

link

Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline

link

January 9, 2026

Avista Therapeutics Expands AI Gene Therapy Platform to Break Barriers in the Delivery of Genetic Medicines

link

December 17, 2025

DNA Nanobots Secures $3.5 Million Investment to Accelerate Non-Viral Gene Therapy Platform

link

Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases

link

Addition Therapeutics Emerges from Stealth with $100 Million in Funding and Significant Progress Advancing Genomic Medicine for Chronic and Rare Diseases

link

December 1, 2025

Regeneron makes $150M bet on Tessera's rare disease gene writing prospect

link

November 18, 2025

Berkeley startup, Magnetic Tides, has developed a new treatment for stroke patients

link

November 17, 2025

Scribe Eyes Clinic After CRISPR Candidates Lower Lipids in Animals

link

November 13, 2025

Sensetics Raises $1.75M to Take Touch Sensing and Haptics into the Digital Age

link

November 12, 2025

Ansa Biotechnologies Sets New Standard in Long, Complex DNA

link

November 6, 2025

Travertine selected by Arianne for partnership on next-gen phosphate technology

link

Pow.Bio, Bühler, and ATV Technologies Scale Up Continuous Biomanufacturing Platform to 3,000 Liters

link

November 4, 2025

Azalea Therapeutics Launches with $82 Million Financing to Redefine Precision Genomic Medicines by Engineering Cells Directly Inside Each Patient

link

October 31, 2025

Strategic Radiology and InkSpace Imaging Partner to bring Flexible MR Coil Innovation to Independent Private Radiology Practices Nationwide

link